نتائج البحث

Opioid and sedative requirements in extracorporeal membrane oxygenation patients on hydromorphone versus fentanyl.

• Authors : Browder, Kelsey¹ (AUTHOR) ; Wanek, Matthew² (AUTHOR); Wang, Lu³ (AUTHOR)

• Source: Artificial Organs. May2022, Vol. 46 Issue 5, p878-886. 9p.

تفاصيل العنوان

Long-Term Stability of Hydromorphone in Human Plasma Frozen at −20°C for Three Years Quantified by LC-MS/MS.

• Authors : Wehrfritz, Andreas¹ (AUTHOR); Schmidt, Stefanie¹ (AUTHOR); Ihmsen, Harald¹ (AUTHOR)

• Source: International Journal of Analytical Chemistry. 6/28/2022, p1-8. 8p.

تفاصيل العنوان

Hydromorphone population pharmacokinetics in pediatric surgical patients.

• Authors : Balyan, Rajiv^1,2,3 (AUTHOR); Dong, Min^2,4 (AUTHOR); Pilipenko, Valentina⁵ (AUTHOR)

• Source: Pediatric Anesthesia. Oct2020, Vol. 30 Issue 10, p1091-1101. 11p.

تفاصيل العنوان

Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment.

• Authors : Dunn KE; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Huhn AS

Subjects: Analgesics, Opioid* ; Hydromorphone* ; Receptors, Opioid, mu*/Receptors, Opioid, mu*/Receptors, Opioid, mu*/genetics

• Source: Addiction biology [Addict Biol] 2024 Jan; Vol. 29 (1), pp. e13355.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9604935 Publication Model: Print Cited Medium:

تفاصيل العنوان

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.

• Authors : Bansback N; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St Paul's Hospital, Vancouver, British Columbia, Canada.; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Subjects: Hydromorphone/Hydromorphone/Hydromorphone/*therapeutic use ; Narcotics/Narcotics/Narcotics/*therapeutic use ; Opiate Substitution Treatment/Opiate Substitution Treatment/Opiate Substitution Treatment/*methods

• Source: Addiction (Abingdon, England) [Addiction] 2018 Jul; Vol. 113 (7), pp. 1264-1273. Date of Electronic Publication: 2018 Mar 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Chemical-induced aseptic meningitis as a result of intrathecal hydromorphone therapy: Case report.

• Authors : Willhite, Sydney¹ ; Juloori, Sangeeta²

• Source: Clinical Case Reports. Aug2021, Vol. 9 Issue 8, p1-4. 4p.

تفاصيل العنوان

Resolution of Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid Rotation to Fentanyl: A Case Series.

• Authors : Veizi, Elias^1,2; Tornero‐Bold, Melissa^2,3; Hayek, Salim M.^2,3

• Source: Pain Practice. Jul2016, Vol. 16 Issue 6, pE94-E98. 5p.

تفاصيل العنوان

Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS® hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain.

• Authors : Richarz, Ute¹; Waechter, Sandra¹; Sabatowski, Rainer²

• Source: Pain Practice. Jan2013, Vol. 13 Issue 1, p30-40. 11p. 1 Diagram, 4 Charts, 4 Graphs.

تفاصيل العنوان

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.

• Authors : Oviedo-Joekes E; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St. Paul's Hospital, Vancouver, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, Canada.

Subjects: Opiate Substitution Treatment*; Heroin/Heroin/Heroin/*therapeutic use ; Hydromorphone/Hydromorphone/Hydromorphone/*therapeutic use

• Source: Drug and alcohol review [Drug Alcohol Rev] 2018 Jan; Vol. 37 (1), pp. 137-146. Date of Electronic Publication: 2017 Jun 08.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 9015440 Publication Model: Print-Electronic Cited

تفاصيل العنوان

Results of a Double-blind, Placebo-controlled, Fixed-dose Assessment of Once-daily OROS® Hydromorphone ER in Patients with Moderate to Severe Pain Associated with Chronic Osteoarthritis.

• Authors : Rauck, Richard¹; Rapoport, Ronald²; Thipphawong, John³

• Source: Pain Practice. Jan2013, Vol. 13 Issue 1, p18-29. 12p. 2 Diagrams, 4 Charts, 2 Graphs.

تفاصيل العنوان